Back to today’s briefing

Story perspectives

Global Cancer Vaccine Market to Hit $1.46 Billion by 2032

1/3/2025

28 2

Summary

Story summary

The Global Dendritic Cell Cancer Vaccine Market is set to soar from USD 652.52 million in 2023 to an impressive USD 1.46 billion by 2032, fueled by breakthroughs in immunotherapy and tailored cancer treatments. With industry giants like GlaxoSmithKline and 3M at the forefront, North America stands as the leading market, promising hope for countless patients.

1 of 1

Story summary

The Global Dendritic Cell Cancer Vaccine Market is set to soar from USD 652.52 million in 2023 to an impressive USD 1.46 billion by 2032, fueled by breakthroughs in immunotherapy and tailored cancer treatments. With industry giants like GlaxoSmithKline and 3M at the forefront, North America stands as the leading market, promising hope for countless patients.